Sharon Rudo

Sharon Rudo currently serves as the Vice President of Drug Safety at BridgeBio since August 2023. Prior to this role, Sharon held multiple positions at Organon, including Associate Vice President for Therapeutic Area Lead Business Development Safety and Executive Director for Women's Health TA Lead Clinical Safety from June 2021 to August 2023. Sharon's extensive experience at Merck from November 2014 to June 2021 included roles as Executive Director and Senior Director of Clinical Safety and Risk Management in the Vaccines division. Earlier in Sharon's career, roles at GSK involved positions as Safety Development Leader and Medical Director in Global Clinical Safety & Pharmacovigilance. Sharon began professional practice as OB/Gyn and Teaching Faculty at Main Line Health from August 2004 to March 2011. Educational credentials include a Doctor of Medicine degree from The Lankenau Hospital (2000-2004), a Bachelor of Arts in History and Sociology of Science from the University of Pennsylvania (1993-1995), and studies at the University of Richmond (1992-1993).